Modulation of dopamine release by striatal 5-HT2C receptors - Test2 - elhamkhani - TriplyDB

Modulation of dopamine release by striatal 5-HT2C receptors

Modulation of dopamine release by striatal 5-HT2C receptors

http://www.wikidata.org/entity/Q28304071

about

A systematic, updated review on the antidepressant agomelatine focusing on its melatonergic modulation Mirtazapine, and mirtazapine-like compounds as possible pharmacotherapy for substance abuse disorders: evidence from the bench and the bedside Serotonin 5-HT2 receptor interactions with dopamine function: implications for therapeutics in cocaine use disorder Domestication of the dog from the wolf was promoted by enhanced excitatory synaptic plasticity: a hypothesis Psychedelics 5-hydroxytryptamine 2C receptors in the dorsal striatum mediate stress-induced interference with negatively reinforced instrumental escape behavior.5-HT2C receptors in the basolateral amygdala and dorsal striatum are a novel target for the anxiolytic and antidepressant effects of exercise Pharmacologic mechanisms of serotonergic regulation of dopamine neurotransmission.Impact of serotonin 2C receptor null mutation on physiology and behavior associated with nigrostriatal dopamine pathway function Deep brain stimulation reveals emotional impact processing in ventromedial prefrontal cortex.The serotonin 2C receptor antagonist SB 242084 exhibits abuse-related effects typical of stimulants in squirrel monkeys Mirtazapine alters cue-associated methamphetamine seeking in rats The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants.Involvement of 5-HT receptors in the development and expression of methamphetamine-induced behavioral sensitization: 5-HT receptor channel and binding study.Dopamine and serotonin receptor binding and antipsychotic efficacy.Dopamine, but not serotonin, regulates reversal learning in the marmoset caudate nucleus Fine-tuning serotonin2c receptor function in the brain: molecular and functional implications Distribution of VGLUT3 in highly collateralized axons from the rat dorsal raphe nucleus as revealed by single-neuron reconstructions.Opposite effects of PSD-95 and MPP3 PDZ proteins on serotonin 5-hydroxytryptamine2C receptor desensitization and membrane stability Running Reduces Uncontrollable Stress-Evoked Serotonin and Potentiates Stress-Evoked Dopamine Concentrations in the Rat Dorsal Striatum.Role of 5-HT₂C receptors in effects of monoamine releasers on intracranial self-stimulation in rats 5-HT(2A) receptor blockade and 5-HT(2C) receptor activation interact to reduce cocaine hyperlocomotion and Fos protein expression in the caudate-putamen Tic disorders: neural circuits, neurochemistry, and neuroimmunology.Transcranial direct-current stimulation increases extracellular dopamine levels in the rat striatum.Role of the serotonin system in ADHD: treatment implications.Neurosurgical strategies for Gilles de la Tourette's syndrome.Characterization of 5-HT3 receptor mutations identified in schizophrenic patients.Blonanserin - A Novel Antianxiety and Antidepressant Drug? An Experimental Study.Building a better antipsychotic: receptor targets for the treatment of multiple symptom dimensions of schizophrenia.Striatal serotonin 2C receptors decrease nigrostriatal dopamine release by increasing GABA-A receptor tone in the substantia nigra.Mechanism of action of trazodone: a multifunctional drug.Analysis of the Serotonergic System in a Mouse Model of Rett Syndrome Reveals Unusual Upregulation of Serotonin Receptor 5b A novel aminotetralin-type serotonin (5-HT) 2C receptor-specific agonist and 5-HT2A competitive antagonist/5-HT2B inverse agonist with preclinical efficacy for psychoses.Opponency revisited: competition and cooperation between dopamine and serotonin.Presynaptic control of serotonin on striatal dopamine function.Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology.Developmental neuroplasticity and the origin of neurodegenerative diseases.The role of different serotonin receptor subtypes in seizure susceptibility.Pharmacogenetics informed decision making in adolescent psychiatric treatment: a clinical case report.Fluoxetine Administration Exacerbates Oral Tremor and Striatal Dopamine Depletion in a Rodent Pharmacological Model of Parkinsonism.

P2860

Q22305782-72205CE5-1D30-42B9-AFE5-97052948B78C Q24622161-01376443-D1E1-4241-BD37-996D206DEBD6 Q27015917-8DFA5463-778F-4EAE-AC1B-47EE5EDD3772 Q28251117-3A3E6461-2165-47E5-84CE-23A78C954A93 Q30359998-0FB3813C-C75A-4430-90A4-69667653EE64 Q30460367-D410802D-E401-4126-966E-52F510FF8140 Q30462731-8C3EBA85-37B1-4D56-9780-260D30C6F00F Q30493133-049A2332-0F3E-47E3-908F-3B6D138B25AE Q30499670-4EE17E74-CF0F-4D18-BAB0-76DE0AC6BAD1 Q33517640-C227E5A0-02D6-4BFE-8FA9-FB05F173F6E5 Q34280398-419F03F7-2171-43FF-9E0D-AC044043B479 Q34462084-96D2E99E-4CEE-4BE6-9985-415D1AB18067 Q34497909-DFBA98C2-4B22-4AB2-9AED-263659C8E6B7 Q34561864-9FE837B2-FAB6-4728-9833-72B67BF76430 Q34605995-BE1BC616-1520-4F86-8757-DE9A2FF300BD Q34877029-AAA84274-76D8-43CA-9515-6A55656DE408 Q35072763-5A6F851D-352E-4BEA-988C-4A8728EE4C23 Q35087896-6B5DE34E-5755-4ED0-B2AF-C4642790055F Q35128324-E66C41DE-605D-47E3-8119-935E5756C25E Q35837495-F253FBF1-51DC-4F88-B979-AD74EAF6657B Q35952202-5F75D877-261B-472C-89D2-9877C61EAB6E Q36334398-5E52F1B3-10FC-40EA-ADD9-B25D9DBCC091 Q36592783-C3821BC4-7C63-43C1-AC52-E147CCFEABCF Q36756465-E98E1512-25D3-43D1-8D4B-B19858B445D7 Q36972698-A619D99C-A252-422B-8830-67DCFC5D9734 Q37106950-CDFEFBC2-5189-44BB-A3CF-31384EBE80DE Q37112926-1CA01D23-E83F-41CC-8B60-CD4FDEC0E78E Q37352996-266E17EE-4579-4B19-AAE6-19F2B5BD51BC Q37358657-CA0307F9-4288-4E93-987D-1299B4D0903A Q37671124-381CD3B1-06D2-4B54-A7B8-5E986C41D0CF Q37679880-089D0C04-949E-4BA1-9AA2-6A6CF35B3AFB Q37685373-DB1D3592-E8B6-484A-8330-58FC27572467 Q37707718-EA095775-C956-457F-9FDD-76D1D98E8C3D Q37794770-266EB07D-AC9F-4836-BBD2-756409B979F0 Q37800812-51C794AC-71AF-410A-BF3D-75C249D93A1D Q38101499-0875C8EA-59BC-4E7C-97DB-1D5FE58C8A90 Q38109214-485C0DE8-0244-4562-A0E3-7311AD8FA396 Q38162732-1DE8C8BE-438A-4321-99C8-D0818DBA3EB1 Q39035865-8C7E63A1-B16E-479D-87DE-1962064F9704 Q41249072-7689E727-C88B-4DE9-A092-790B4EC0D14B

P2860

Modulation of dopamine release by striatal 5-HT2C receptors

http://www.wikidata.org/entity/Q28304071

description

2005 nî lūn-bûn

@nan

2005 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի մարտին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

name

Modulation of dopamine release by striatal 5-HT2C receptors

@ast

Modulation of dopamine release by striatal 5-HT2C receptors

@en

Modulation of dopamine release by striatal 5-HT2C receptors

@nl

type

label

Modulation of dopamine release by striatal 5-HT2C receptors

@ast

Modulation of dopamine release by striatal 5-HT2C receptors

@en

Modulation of dopamine release by striatal 5-HT2C receptors

@nl

prefLabel

Modulation of dopamine release by striatal 5-HT2C receptors

@ast

Modulation of dopamine release by striatal 5-HT2C receptors

@en

Modulation of dopamine release by striatal 5-HT2C receptors

@nl

P1433

Q28304071-BB7AC682-C338-44AE-8E95-B439E57902DE

P1476

Q28304071-FBB51C56-F053-49C6-BB19-1748F6FAB0C0

P2093

Q28304071-561DEBE7-4217-4911-B24E-4698F329BDA7

Q28304071-8D6BF724-1CD0-4C58-A5AA-B66124D74224

Q28304071-B094A70D-083B-471E-9E05-E6C652554A5B

Q28304071-B580764E-3E40-4E30-BE57-EC4FAA7023D4

Q28304071-C80B9735-6187-44AD-A25D-C0B17FB56464

P2860

Q28304071-7FBD7022-2481-4301-863D-73AF559213C4

Q28304071-C566CF61-B0BD-4FA6-837A-529E6DEAC8EA

P304

Q28304071-3E9E2919-861C-4A76-9023-46240AB550DE

P31

Q28304071-23CBF840-1D29-4EFF-A4F2-4F2EDA7AAD28

P356

Q28304071-81EB437B-4AB5-4D72-BE27-616E39182C92

P407

Q28304071-DDEF2188-8886-4674-A7EA-5577495300AB

P433

Q28304071-E3168EC8-7A26-4825-BD76-04145FD9D070

P478

Q28304071-47AC8AB4-C938-4F53-A669-667E6ADC175B

P577

Q28304071-AC257F3D-5FF8-4AF4-93A5-6667A9EF7187

P5875

Q28304071-D8476483-EFE9-4E1A-94BA-6AE80A4E5FCF

P698

Q28304071-1942AC68-919C-49FE-9B62-C9B1F5949B41

P921

Q28304071-D77E047D-4E89-4BB9-BC66-C86CCC8838ED

Q28304071-c8ebd3e5-32bf-40c2-8fd9-6f1e4177fe97

P356

P1433

P1476

Modulation of dopamine release by striatal 5-HT2C receptors

@en

P2093

Charles P Pluto

http://www.w3.org/2001/XMLSchema#string

Elizabeth A Pehek

http://www.w3.org/2001/XMLSchema#string

Gregory J Yavanian

http://www.w3.org/2001/XMLSchema#string

Hewlet G McFarlane

http://www.w3.org/2001/XMLSchema#string

Katherine D Alex

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro and in vivo profile of SB 206553, a potent 5-HT2C/5-HT2B receptor antagonist with anxiolytic-like properties

Implications of normal brain development for the pathogenesis of schizophrenia

P304

242-51

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/SYN.20109

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2005-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8062643

http://www.w3.org/2001/XMLSchema#string

P698

15668911

http://www.w3.org/2001/XMLSchema#string

P921

corpus striatum